HR Execs on the Move

NeuroVasx

www.neurovasx.com

 
NeuroVasx is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.neurovasx.com
  • 7351 Kirkwood Ln N Ste 112
    Maple Grove, MN USA 55369
  • Phone: 763.315.0013

Executives

Name Title Contact Details

Similar Companies

Neurowave Medical Technologies

Neurowave Medical Technologies is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifestar Ambulance

Lifestar Ambulance is a Centralia, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith Northview Hospital

Smith Northview Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Valdosta, GA. To find more information about Smith Northview Hospital, please visit www.smithhospital.com.

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

cbdMD

Discover our THC-free, superior CBD products. Featuring award-winning, high-quality hemp oil. Feel & taste the difference. Visit to learn more.